Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1617 in Healthy Adult Non-Asian and Japanese Subjects Including Assessment of a Food Effect
Clinical trial NCT04077879 · COMPLETED
Trial details
- NCT number
- NCT04077879
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-19
- Primary completion
- 2021-06-12
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.